stockportfolio.pro
Phibro Animal Health Corporation P/E Ratio 2012–2025
Phibro Animal Health Corporation (PAHC) annual price-to-earnings ratio by fiscal year, computed from SEC filings. Compound growth +0.2%/yr over 13 years.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | 21.09 | -92.1% |
| FY 2024 | 268.38 | +1616.3% |
| FY 2023 | 15.64 | +9.8% |
| FY 2022 | 14.25 | -24.7% |
| FY 2021 | 18.91 | -30.4% |
| FY 2020 | 27.16 | +37.2% |
| FY 2019 | 19.81 | -16.7% |
| FY 2018 | 23.78 | +25.3% |
| FY 2017 | 18.98 | +158.9% |
| FY 2016 | 7.33 | -64.4% |
| FY 2015 | 20.61 | — |
| FY 2014 | — | — |
| FY 2013 | — | — |
| FY 2012 | — | — |
Source: Phibro Animal Health Corporation SEC filings — fiscal-year-end price ÷ diluted EPS. Refreshed nightly.
See the full picture for Phibro Animal Health Corporation
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freePhibro Animal Health Corporation — frequently asked questions
What is Phibro Animal Health Corporation's price-to-earnings ratio?
Phibro Animal Health Corporation (PAHC) reported price-to-earnings ratio of 21.09 for fiscal year 2025, per its SEC filings.
How has Phibro Animal Health Corporation's price-to-earnings ratio changed over time?
Between fiscal 2012 and 2025, PAHC's price-to-earnings ratio grew at roughly 0.2% per year (compound annual rate), from 20.61 to 21.09.
Where does this data come from?
Figures are computed from Phibro Animal Health Corporation's official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.